LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1373-1382

  Marek, Gerard J ^a,b   Aghajanian, George K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BICUCULLINE; LYSERGIDE; NORADRENALIN; PARTIAL AGONIST; PHENETHYLAMINE DERIVATIVE; PSYCHEDELIC AGENT; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN CREATININE SULFATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MALE; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; PYRIFORM CORTEX; RAT; RECEPTOR AFFINITY; VOLTAGE CLAMP;

ACTION POTENTIALS; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; AMPHETAMINES; ANIMALS; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROBENZENES; HALLUCINOGENS; INTERNEURONS; LYSERGIC ACID DIETHYLAMIDE; MALE; NOREPINEPHRINE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0030434487     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. 1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 90: 408-412, 1993.
2. AGHAJANIAN, G. K. AND BING, O. H. L.: Persistance of lysergic acid diethylamide in the plasma of human subjects. Clin. Pharmacol. Ther. 5: 611-614, 1964.
3. AGHAJANIAN, G. K. AND RASMUSSEN, K.: Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices. Synapse 3: 331-338, 1989.
4. 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40: 399-412, 1991.
5. BENNETT, J. P. AND SNYDER, S. H.: Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: Relationship to serotonin receptors. Brain Res. 94: 523-544, 1975.
6. 2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide. Mol. Pharmacol. 42: 826-830, 1992.
7. DAVIES, M. F., DEISZ, R. A., PRINCE, D. A. AND PEROUTKA, S. J.: Two distinct effects of 5-hydroxytryptamine on single cortical neurons. Brain Res. 423: 347-352, 1987.
8. ERLANDER, M. G., LOVENBERG, T. W., BARON, B. M., DELECEA, L., DANIELSON, P. E., RACKE, M., SLONE, A. L., SIEGEL, B. W., FOYE, P. E., CANNON, K., BURNS, J. AND SUTCLIFFE, J. G.: Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Proc. Natl. Acad. Sci. U.S.A. 90: 3452-3456, 1993.
9. 2 receptors in P11 cells. Mol. Pharmacol. 43: 726-733, 1993.
10. h: Intracellular studies in rat facial motoneurons. Synapse 13: 123-134, 1993.
11. 3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes. Eur. J. Pharmacol. 97: 87-93, 1984.
12. GELLMAN, R. L. AND AGHAJANIAN, G. K.: Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res. 600: 63-73, 1993.
13. 2 receptor-mediated excitation of interneurons in piriform cortex: Antagonism by atypical antipsychotic drugs. Neuroscience 58: 515-525, 1994.
14. 4 receptor: Molecular cloning and pharmacological characterization of two splice variants. EMJO J. 14: 2806-2815, 1995.
15. 2 agonists or antagonists? Neuropsychopharmacology 3: 509-517, 1990.
16. 2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 35: 2505-2511, 1984.
17. HAWKS, R. L. AND CHIANG, C. N.: Urine testing for drugs of abuse. National Institute on Drug Abuse, Research Monograph #73. U.S. Department of Health and Human Services, DHHS Publication No. (ADDM)87-1481, Rockville, MD, 1986.
18. 1 recognition sites. J. Recept. Res. 8: 59-81, 1988.
19. 125I-lysergic acid diethylamide binding to serotonin receptors in rat frontal cortex. J. Neurochem. 43: 601-606, 1984.
20. LAUBSCHER, A., PLETSCHER, A. AND NOLL, H.: Interaction of D-LSD with blood platelets of rabbits: Shape change and specific binding. J. Pharmacol. Exp. Ther. 216: 385-389, 1981.
21. 7) implicated in the regulation of mammalian circadian rhythms. Neuron 11: 449-458, 1993b.
22. 1E-like rat and human 5-hydroxytryptamine receptor genes. Proc. Natl. Acad. Sci. U.S.A. 90: 2184-2188, 1993a.
23. 2 receptors. Mol. Pharmacol. 31: 194-199, 1987.
24. 2A antagonist. Eur. J. Pharmacol. 259: 137-141, 1994.
25. 1B-Adrenoreceptor mediated excitation of piriform cortical interneurons. Eur. J. Pharmacol., 305: 95-100, 1996.
26. 2A receptor-mediated excitatory effects of serotonin on interneurons in rat piriform cortex. Synapse 21: 123-130, 1995.
27. 5B receptors define a new family of serotonin receptors: Cloning, functional expression, and chromosomal localization. Mol. Pharmacol. 43: 313-319, 1993.
28. 2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res. 524: 139-143, 1990.
29. MONSMA, F. J., SHEN, Y., WARD, R. P., HAMBLIN, M. W. AND SIBLEY, D. R.: Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43: 320-327, 1993.
30. 3 mediated control of dopaminergic function. Psychopharmacology. 112: suppl., S60-S67, 1993.
31. PAZOS, A., CORTES, R. AND PALACIOS, J. M.: Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346: 231-249, 1985.
32. 3 recognition sites in rat cortical membranes. Eur. J. Pharmacol. 148: 297-299, 1988.
33. 3H]spiroperidol. Mol. Pharmacol. 16: 687-699, 1979.
34. 2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide. J. Pharmacol. Exp. Ther. 247: 918-925, 1988.
35. PIERCE, P. A. AND PEROUTKA, S. J.: d-Lysergic acid diethylamide differentially affects the dual actions of 5-hydroxytryptamine on cortical neurons. Neuropharmacology 29: 705-712, 1990.
36. PIERCE, P. A. AND PEROUTKA, S. J.: Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology 97: 118-122, 1989.
37. 2C receptors. Mol. Brain Res. 23: 163-178, 1994.
38. 2 antagonists. Brain Res. 385: 395-400, 1986.
39. 2 binding affinity. Neuropsychopharmacology 1: 101-107, 1988.
40. 7) activating cAMP formation. Proc. Natl. Acad. Sci. U.S.A. 90: 8547-8551, 1993.
41. 1C receptor activation by hallucinogenic drugs. Psychopharmacology 105: 340-346, 1991.
42. SANDERS-BUSH, E., BURRIS, K. D. AND KNOTH, K.: Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J. Pharmacol. Exp. Ther. 246: 924-928, 1988.
43. SCHREIBER, R., BROCCO, M. AND MILLAN, M. J.: Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the "atypical" antipsychotics, clozapine and risperidone. Eur. J. Pharmacol. 264: 99-102, 1994.
44. 2-activated interneuron. Brain Res. 506: 62-69, 1990.
45. 1activated interneuron. Soc. Neurosci. Abstr. 14: 215, 1988.
46. 2 receptors in interneurons. Synapse 9: 208-218, 1991.
47. 2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: Behavioral, electrophysiological and neurochemical studies. J. Pharmacol. Exp. Ther. 266: 684-691, 1993.
48. 2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94: 213-216, 1988.
49. 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351: 357-373, 1995.
50. 1E receptor. Mol. Pharmacol. 42: 180-185, 1992.